Applied DNA Sciences, Inc.
APDN
$5.37
-$0.14-2.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -31.30% | -58.46% | -74.33% | -78.96% | -68.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -31.30% | -58.46% | -74.33% | -78.96% | -68.52% |
| Cost of Revenue | -38.36% | -59.58% | -69.18% | -75.21% | -69.35% |
| Gross Profit | -17.60% | -56.60% | -81.62% | -85.51% | -66.76% |
| SG&A Expenses | -13.46% | -16.76% | -10.22% | -8.50% | -1.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.64% | -24.79% | -28.22% | -32.59% | -30.13% |
| Operating Income | 9.65% | 2.39% | -28.05% | -35.25% | -30.86% |
| Income Before Tax | 39.54% | -18.03% | 29.28% | -4.50% | -143.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 39.54% | -18.03% | 29.28% | -4.50% | -143.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.72% | -0.30% | 26.22% | 89.96% | 115.75% |
| Net Income | 40.00% | -18.28% | 29.70% | -3.85% | -143.29% |
| EBIT | 9.65% | 2.39% | -28.05% | -35.25% | -30.86% |
| EBITDA | 4.65% | -4.45% | -38.97% | -44.46% | -36.84% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |